toxCSM: comprehensive prediction of small molecule toxicity profiles

Alex G C de Sá1,2,3,4, Yangyang Long2,3,5, Stephanie Portelli1,2,3

  • 1School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane City, Queensland, 4072, Australia.

Insights

Toxicity is a major cause of drug development failure. The toxCSM platform uses computational models to predict toxicity, aiding in the development of safer drugs and agrochemicals.

Area of Science:

  • Computational toxicology
  • Drug discovery and development
  • Environmental and human health risk assessment

Background:

  • Drug discovery is expensive and prone to failure, with toxicity being a primary reason for clinical trial attrition.
  • Existing computational tools for toxicity prediction are limited in scope and scale.
  • There is a need for comprehensive platforms to assess human and environmental toxicity early in drug development.

Purpose of the Study:

  • To present toxCSM, a computational platform for studying and optimizing the toxicity profiles of small molecules.
  • To provide a tool for early identification and optimization of toxicity, thereby reducing drug development costs and timelines.
  • To develop predictive models for a wide range of toxicity properties relevant to drug and agrochemical safety.

Main Methods:

  • Leveraging graph-based signatures, molecular descriptors, and similarity scores.
  • Developing 36 predictive models for various toxicity endpoints.
  • Utilizing 10-fold cross-validation and blind test sets for performance evaluation.

Main Results:

  • Achieved high predictive performance with Area Under the Receiver Operating Characteristic (ROC) Curve (AUC) up to 0.99 and Pearson's correlation coefficients up to 0.94.
  • Demonstrated superior performance compared to alternative methods on both cross-validation and blind test sets.
  • Developed a comprehensive suite of models for diverse toxicity assessments.

Conclusions:

  • toxCSM offers a robust computational solution for predicting small molecule toxicity.
  • The platform can significantly assist in developing safer drugs and agrochemicals by enabling early toxicity profiling.
  • toxCSM is accessible via a user-friendly web server and API for broad scientific use.

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.5K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
8.6K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K